Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
336 participants
OBSERVATIONAL
2023-08-16
2026-08-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Organization of Excitation in People With Atrial Fibrillation
NCT00871390
Noninvasive Mapping Before Surgical Ablation
NCT06803615
Utilizing a Novel Method to Map Sources of Atrial Fibrillation
NCT02523534
Efficacy of Different Ablation Strategies for Controlling Atrial Fibrillation
NCT00379301
Machine Learning in Atrial Fibrillation
NCT05371405
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
successful persistent AF ablation
Cases are defined as successful persistent AF ablation cases (documented freedom from AF during ≥1 year after ablation).
No interventions assigned to this group
failed persistent AF ablation
Controls are defined as failed persistent AF ablation (recurrent, persistent AF in patients with documented well-isolated pulmonary veins).
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. One/First AF ablation procedure (no prior atrial ablation procedures)
3. Documented complete pulmonary vein isolation at the end of the ablation
4. Available uniform, high-quality (as described below) clinical data required to detect AF recurrence during ≥ 1 year after ablation, and/or ECG monitoring (implantable loop recording or repeated long-term ECG monitoring via ECG patch or similar)
Exclusion Criteria
2. Missing data of exposure (AF ablation map), outcome (definition of cases and controls), or covariates
18 Years
89 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
American Heart Association
OTHER
Larisa Tereshchenko, MD, PhD
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Larisa Tereshchenko, MD, PhD
Staff, Associate Professor of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cleveland Clinic
Cleveland, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
American Heart Association Award
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
23IPA1054947
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
23IPA1054947
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.